Pathways to Prevention (P2P) Workshop Program: Can Physical Activity Improve the Health of Wheelchair Users? - POSTPONED

Pathways to Prevention (P2P) Workshop Program: Can Physical Activity Improve the Health of Wheelchair Users? - POSTPONED

March 30, 2020
March 31, 2020

Contact Number: 

301-827-5561

Contact Email: 

https://prevention.nih.gov/contact-us

Location: 

The decision has been made to postpone the NIH Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users?, originally scheduled to take place on March 30-31, 2020. Plans are underway to reschedule the workshop for fall 2020 to best ensure that all workshop panelists, speakers, and attendees can fully engage and participate.

We remain very excited about the opportunities for scientific exchange that this workshop will offer and will share more information about rescheduled dates as soon as possible.  Please visit NIH Guidance on Travel and Meetings.

Event Description: 

This P2P workshop will assess the available scientific evidence through a systematic evidence review, invite numerous speakers to present their research, and engage with a community of wheeled mobility device users to better understand the potential benefits of physical activity interventions for people at risk of using, or currently using, wheeled mobility devices as a result of a disabling injury or illness. The following questions will be addressed:

  1. What is the evidence base on physical activity interventions to prevent obesity, diabetes, and cardiovascular conditions, including evidence on harms of the interventions in people with multiple sclerosis (MS), cerebral palsy (CP), or spinal cord injury (SCI) who are at risk for or currently using a wheeled mobility device?

  2. What are the benefits and harms of physical activity interventions for people with MS, CP, or SCI who are at risk for or currently using a wheeled mobility device?
  3. What are the patient factors that may affect the benefits and harms of physical activity in patients with MS, CP, or SCI who are at risk for or currently using a wheeled mobility device?
  4. What are methodological weaknesses or gaps that exist in the evidence to determine benefits and harms of physical activity in patients with MS, CP, or SCI who are at risk for or currently using a wheeled mobility device?

Sponsoring NIH Institutes, Centers, and Offices

Continuing education credits are not offered for this workshop.